Liposomes and lipid nanoparticles (LNPs) are becoming established as leading materials for the encapsulation and in vivo delivery of a wide range of clinical materials, including drugs, therapeutic agents, mRNA and other APIs. This technology is now used for a wide range of applications, spanning vaccine development, nanomedicines and gene therapy. Optimizing LNP formulations and screening target APIs/payloads requires a combination of flexible LNP synthesis and insightful characterization equipment.
Join this webinar with nanoparticle characterization experts Ben Knappett and Hanna Jankevics Jones, as they share their insights about the most important considerations when making liposomes and lipid nanoparticles (LNPs) with microfluidics.
They will show you:
- How Malvern Panalytical’s analytical techniques can help you characterize and monitor important LNP attributes
- How Dolomite Microfluidics’ automated microfluidic approach to synthesizing LNPs, including key parameters to achieve a reliable and consistent synthesis of LNPs.
- How Dolomite Microfluidics uses the Zetasizer Ultra to streamline LNP optimization and screening